Can someone please explain why this stock has not moved….
One would think with such catalyst near or just months away that there would be interest from biotech community and some talk. What is the true value of this stock with approval, and what are the chances of approval? thnx
healthy risk, VTUS is no longer 65% institutional owned. As of the latest numbers from Nasdaq its down to 44%. There were 2.7 million shares sold out. Thats my concern. A few months ago when I checked it was 65%……not any longer. Unless I am reading wrong numbers.
I don't have a crystal ball but I would think that VEN 307 would be approved next year. Pharmacists are already using the compound but they have to make it themselves and VEN 307 would solve a quality control and efficiency issue. I would hang tight.
Also, I would assume there would be no more prescriptions written for the compounded formulation after VEN 307 is approved. I was a Rogaine user that got the stuff compounded about 18 months before it was approved. After approval, dermatologists all switched to brand name Rogaine. Unfortunately, mgmt. on one of the calls said data isn't collected for compounded drugs, so no clear guidance on the $$$ that would automatically move to VEN 307.